Holen Sie sich die Stockscreener-App
11.12
6.31%
0.6599
Schlusskurs vom Vortag:
$10.46
Offen:
$10.5843
24-Stunden-Volumen:
5,814
Relative Volume:
1.23
Marktkapitalisierung:
$64.92M
Einnahmen:
$503.40K
Nettoeinkommen (Verlust:
$9.17M
KGV:
6.1406
EPS:
1.8109
Netto-Cashflow:
$-604.40K
1W Leistung:
+3.54%
1M Leistung:
+9.99%
6M Leistung:
-1.59%
1J Leistung:
-2.46%
1-Tages-Spanne:
$10.58
$11.12
1-Wochen-Bereich:
$9.90
$11.12
52-Wochen-Spanne:
$8.56
$14.76
Daxor Corporation Stock (DXR) Company Profile
Firmenname
Daxor Corporation
Sektor
Telefon
212-330-8500
Adresse
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
11.12 | 61.07M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
351.31 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.32 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
69.05 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.75 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.38 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-05-16 | Eingeleitet | Ascendiant Capital Markets | Buy |
Daxor Corporation Aktie (DXR) Neueste Nachrichten
Daxor Corporation to Participate in Lake Street’s Tenth Annual BIG10 Conference in New York City - Quiver Quantitative
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference - ca.finance.yahoo.com
Responsive Playbooks and the DXR Inflection - Stock Traders Daily
Daxor Corporation (NASDAQ: DXR) Share Price, DXR Stock News, DXR Share Price & Updates - kalkine.ca
Insider at Daxor (DXR) logs new stock trade - Stock Titan
Daxor reports 16% kit sales growth, expands sales team By Investing.com - Investing.com Nigeria
Daxor reports 16% kit sales growth, expands sales team - Investing.com
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter - GlobeNewswire
Daxor (DXR) posts H1 loss as stock drops 30% - Stock Titan
Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 - marketscreener.com
Daxor Corporation (DXR) Advances 2.72% to $10.03 on Renewed Interest in Blood Volume DiagnosticsWatchlist Stock Ideas - vinanet.vn
Daxor (DXR) Earnings Reading: EPS Comes in Above Forecast in the Latest Reading; Closing Move: Shares Show Limited Movement in the Available RecordQuarterly Earnings - vinanet.vn
Why Is Daxor (NASDAQ:DXR) in Focus Today? - Kalkine Media
What Could Daxor (NASDAQ:DXR) Reveal Today About Its Next Operating Milestones? - kalkinemedia.com
Daxor (DXR) Price and Levels: Moves 0.95% Up to $10.30 for the Current Session; Technical Position - dars.gov.et
Daxor Corporation (DXR) Holds Steady at $10.2 as Trading Range NarrowsRetail Sentiment - vinanet.vn
Liquidity Mapping Around (DXR) Price Events - Stock Traders Daily
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daxor Corp (DXR) Stock News Today - TradingKey
Why (DXR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
DXR Q3 2007 Earnings: EPS of $0.43 Blows Past Estimates in 325.7% UpsetAnalyst Drop Coverage - vinanet.vn
Daxor Launches Blood Testing Lab in Eastern Kansis - marketscreener.com
Daxor Corporation Initiates Outpatient Blood Volume Analysis Program in Kansas - marketscreener.com
Daxor Corporation Launches Outpatient Blood Volume Analysis Program at Kansas Healthcare Facility - Quiver Quantitative
Daxor Launches New Blood Volume Analysis Program - Intellectia AI
Daxor launches outpatient blood volume analysis service in Kansas, enhancing precision diagnostics. - Pluang
Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DXR|Daxor Corp|Price:11.050|Chg%:+0.600 - TradingKey
Daxor Corp (DXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Daxor Corp (DXR) Balance Sheet - TradingKey
Daxor Corp (DXR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Daxor Corp (DXR) Earnings Date & Reports & Earnings News - TradingKey
Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Daxor Corporation Declines 3.77%: Support Levels in FocusTrend Continuation Trade - dars.gov.et
Daxor Corp (DXR) Institutional Confidence - TradingKey
Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DXR|Daxor Corp|Price:9.800|Chg%:-0.403 - TradingKey
Daxor Corporation (DXR) Slips 2.38% as Stock Nears Key SupportBollinger Squeeze - dars.gov.et
Daxor Corp (DXR) Cash Flow - TradingKey
Daxor Corporation (DXR) Holds Steady Near Support in Tight Trading RangeHigh Volume Stocks - vinanet.vn
Daxor (DXR) Proxy filing Summary - Quartr
Understanding Momentum Shifts in (DXR) - Stock Traders Daily
DXR Q3 2007 Earnings: EPS Surges 325.7% Above EstimatesEarnings Growth Forecast - vinanet.vn
DXR Q3 2007 Earnings: EPS Surges 325% Above Estimates, Driving Strong Stock AppreciationEPS Growth Report - vinanet.vn
Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Nigeria
Daxor to exhibit blood volume analyzer at dysautonomia conference - Investing.com
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas - The Manila Times
Daxor Corporation Announces First-Time Exhibition at the - GlobeNewswire
Daxor debuts Blood Volume Analyzer at Dysautono... - Pluang
DXR Q3 2007 Earnings: EPS Surges 326% Above Estimates, Stock Climbs $1.44Earnings Miss Alert - DonanımHaber
Finanzdaten der Daxor Corporation-Aktie (DXR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):